Clinical Trial Detail

NCT ID NCT01319981
Title Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphocytic leukemia

lymphocytic leukemia

Therapies

Pegfilgrastim

Imatinib

Filgrastim

Rituximab

Doxorubicin

Dexamethasone

Vincristine

Cyclophosphamide

Age Groups: adult

No variant requirements are available.